T. L. Aghaloo, RANKL Inhibitors Induce Osteonecrosis of the Jaw in Mice With Periapical Disease, Journal of Bone and Mineral Research, vol.101, issue.1, pp.843-54, 2014.
DOI : 10.1016/j.tripleo.2005.06.022

T. L. Aghaloo, R. Hazboun, and S. Tetradis, Pathophysiology of Osteonecrosis of the Jaws, Oral and Maxillofacial Surgery Clinics of North America, vol.27, issue.4, pp.489-496, 2015.
DOI : 10.1016/j.coms.2015.06.001

A. , P. Constantinescu, and F. , A Review of Osteoporosis in the Older Adult, Clinics in Geriatric Medicine, vol.33, issue.1, pp.27-40, 2017.

M. R. Allen, Medication-Related Osteonecrosis of the Jaw, Oral and Maxillofacial Surgery Clinics of North America, vol.27, issue.4, pp.497-508, 2015.
DOI : 10.1016/j.coms.2015.06.002

M. Allen and B. D. , Chapter 4 Bone Modeling and Remodeling, Basic and Applied Bone Biology, 2014.

P. Aspenberg and J. Schilcher, Atypical Femoral Fractures, Bisphosphonates, and Mechanical Stress, Current Osteoporosis Reports, vol.105, issue.2, pp.189-193, 2014.
DOI : 10.3109/17453674.2013.859423

G. I. Baroncelli and S. Bertelloni, The Use of Bisphosphonates in Pediatrics, Hormone Research in Paediatrics, vol.82, issue.5, pp.290-302, 2014.
DOI : 10.1159/000365889

S. Battaglia, Impact of oncopediatric dosing regimen of zoledronic acid on bone growth: Preclinical studies and case report of an osteosarcoma pediatric patient, Journal of Bone and Mineral Research, vol.397, issue.10, pp.2439-51, 2011.
DOI : 10.1038/16852

H. Begam, Strategies for delivering bone morphogenetic protein for bone healing, Materials Science and Engineering: C, vol.70, pp.1-14, 2016.
DOI : 10.1016/j.msec.2016.09.074

R. N. Bhatt, S. A. Hibbert, and C. F. Munns, The use of bisphosphonates in children: review of the literature and guidelines for dental management, Australian Dental Journal, vol.56, issue.625-634, pp.9-19, 2014.
DOI : 10.1111/j.1834-7819.2010.01283.x

V. Bradaschia-correa, Effect of alendronate on endochondral ossification in mandibular condyles of growing rats, European Journal of Histochemistry, vol.56, issue.2, pp.149-153, 2012.
DOI : 10.4081/ejh.2012.24

V. Bradaschia-correa, Immunolocalization of Smad-4 in developing molar roots of alendronate-treated rats, Archives of Oral Biology, vol.58, issue.11, pp.1744-1750, 2013.
DOI : 10.1016/j.archoralbio.2013.06.002

A. Bringmann, Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells, Leukemia, vol.62, issue.4, pp.732-740, 2007.
DOI : 10.4049/jimmunol.175.8.4990

I. Buhaescu and H. Izzedine, Mevalonate pathway: A review of clinical and therapeutical implications, Clinical Biochemistry, vol.40, issue.9-10, pp.9-10575, 2007.
DOI : 10.1016/j.clinbiochem.2007.03.016

B. Castaneda, Bone resorption control of tooth eruption and root morphogenesis: Involvement of the receptor activator of NF-??B (RANK), Journal of Cellular Physiology, vol.228, issue.1, pp.74-85, 2011.
DOI : 10.1080/03008200390181753

A. Chandra, Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis, The FASEB Journal, vol.32, issue.1, pp.1-12, 2017.
DOI : 10.1096/fj.201700375R

M. Cicciu, Recombinant Human Bone Morphogenetic Protein Type 2 Application for a Possible Treatment of Bisphosphonates-Related Osteonecrosis of the Jaw, Journal of Craniofacial Surgery, vol.23, issue.3, pp.784-788, 2012.
DOI : 10.1097/SCS.0b013e31824dbdd4

R. E. Coleman and E. V. Mccloskey, Bisphosphonates in oncology, Bone, vol.49, issue.1, pp.71-76, 2011.
DOI : 10.1016/j.bone.2011.02.003

F. P. Coxon, The gunmetal mouse reveals Rab geranylgeranyl transferase to be the major molecular target of phosphonocarboxylate analogues of bisphosphonates, Bone, vol.49, issue.1, pp.111-121, 2011.
DOI : 10.1016/j.bone.2011.03.686

M. Diniz-freitas and J. Limeres, Prevention of medication-related osteonecrosis of the This article is protected by copyright. All rights reserved jaws secondary to tooth extractions. A systematic review, Medicina Oral Patologia Oral y Cirugia Bucal, vol.21, issue.2, pp.250-259, 2016.

G. M. Donnell, Antiseptics and Disinfectants : Activity, Action , and Resistance, vol.12, issue.1, pp.147-179, 1999.

G. F. Draenert, Dexrazoxane shows cytoprotective effects in zoledronic acidtreated human cells in vitro and in the rabbit tibia model in vivo Journal of cranio-maxillofacial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, pp.40-369, 2012.

F. H. Ebetino, The relationship between the chemistry and biological activity of the bisphosphonates, Bone, vol.49, issue.1, pp.20-33, 2011.
DOI : 10.1016/j.bone.2011.03.774

G. Eghbali-fatourechi, Bisphosphonate therapy in pediatric patients, Journal of Diabetes & Metabolic Disorders, vol.32, issue.9, p.109, 2014.
DOI : 10.1080/10790268.2009.11760776
URL : https://doi.org/10.1186/s40200-014-0109-y

R. Enciso, Assessing the utility of serum C-telopeptide cross-link of type 1 collagen as a predictor of bisphosphonate-related osteonecrosis of the jaw, The Journal of the American Dental Association, vol.147, issue.7, pp.551-560, 2016.
DOI : 10.1016/j.adaj.2016.02.011

K. D. Evans, Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta, Bone, vol.32, issue.3, pp.268-274, 2003.
DOI : 10.1016/S8756-3282(02)00974-2

D. Fabbro, M. Gallesio, G. Mozzati, and M. , Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature, European Journal of Cancer, vol.51, issue.1, pp.62-74, 2015.
DOI : 10.1016/j.ejca.2014.10.015

M. Fazil, Bisphosphonates: therapeutics potential and recent advances in drug delivery, Drug Delivery, vol.33, issue.1, pp.1-9, 2015.
DOI : 10.7326/0003-4819-144-10-200605160-00009
URL : http://www.tandfonline.com/doi/pdf/10.3109/10717544.2013.870259?needAccess=true

A. C. Feldstein, Incidence and demography of femur fractures with and without atypical features, Journal of Bone and Mineral Research, vol.55, issue.9, pp.977-986, 2012.
DOI : 10.1111/j.1532-5415.2007.01310.x

J. J. Freiberger, What Is the Role of Hyperbaric Oxygen in the Management of Bisphosphonate-Related Osteonecrosis of the Jaw: A Randomized Controlled Trial of Hyperbaric Oxygen as an Adjunct to Surgery and Antibiotics, Journal of Oral and Maxillofacial Surgery, vol.70, issue.7, pp.1573-1583, 2012.
DOI : 10.1016/j.joms.2012.04.001

P. L. Fung, Pharmacogenetics of Bisphosphonate-associated Osteonecrosis of the Jaw, Oral and Maxillofacial Surgery Clinics of North America, vol.27, issue.4, pp.537-546, 2015.
DOI : 10.1016/j.coms.2015.06.005

N. Garrido-mesa, A. Zarzuelo, and J. Gálvez, Minocycline: far beyond an antibiotic, British Journal of Pharmacology, vol.293, issue.2, pp.337-352, 2013.
DOI : 10.1001/jama.293.16.2003
URL : http://onlinelibrary.wiley.com/doi/10.1111/bph.12139/pdf

L. Ginaldi, M. Martinis, and . De, Osteoimmunology and Beyond, Current Medicinal Chemistry, vol.23, issue.33, pp.1-21, 2016.
DOI : 10.2174/0929867323666160907162546
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204071/pdf

G. Greenstein, C. Berman, and R. Jaffin, Chlorhexidine: An Adjunct to Periodontal Therapy, Journal of Periodontology, vol.76, issue.1, pp.370-377, 1986.
DOI : 10.1111/j.1600-051X.1977.tb00055.x

S. Hafner, Photodynamic Inactivation of Actinomyces naeslundii in Comparison With Chlorhexidine and Polyhexanide???A New Approach for Antiseptic Treatment of Medication-Related Osteonecrosis of the Jaw?, Journal of Oral and Maxillofacial Surgery, vol.74, issue.3, pp.516-522, 2016.
DOI : 10.1016/j.joms.2015.09.014

N. Hagelauer, In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes, Clinical Oral Investigations, vol.9, issue.32, pp.139-187, 2015.
DOI : 10.2174/1381612033453640

I. S. Hamadeh, B. A. Ngwa, and Y. Gong, Drug induced osteonecrosis of the jaw, Cancer Treatment Reviews, vol.41, issue.5, pp.455-464, 2015.
DOI : 10.1016/j.ctrv.2015.04.007

D. Heymann, Bisphosphonates: new therapeutic agents for the treatment of bone tumors, Trends in Molecular Medicine, vol.10, issue.7, pp.337-380, 2004.
DOI : 10.1016/j.molmed.2004.05.007

D. Heymann, Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma, Bone, vol.37, issue.1, pp.74-86, 2005.
DOI : 10.1016/j.bone.2005.02.020

N. Hinchy, Osteonecrosis of the jaw ??? Prevention and treatment strategies for oral health professionals, Oral Oncology, vol.49, issue.9, pp.878-886, 2013.
DOI : 10.1016/j.oraloncology.2013.06.008

T. Hiraga, Administration of the Bisphosphonate Zoledronic Acid During Tooth Development Inhibits Tooth Eruption and Formation and Induces Dental Abnormalities in Rats, Calcified Tissue International, vol.45, issue.1, pp.502-510, 2010.
DOI : 10.1177/00220345890680021001

S. Hoefert, Zoledronate but not denosumab suppresses macrophagic differentiation of THP-1 cells. An aetiologic model of bisphosphonate-related osteonecrosis of the jaw (BRONJ), Clinical Oral Investigations, vol.279, issue.5, pp.1307-1325, 2015.
DOI : 10.1074/jbc.M403968200

S. Hoefert and H. Eufinger, Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, pp.463-472, 2010.

R. N. Howie, Removal of pamidronate from bone in rats using systemic and local chelation, Archives of Oral Biology, vol.60, issue.12, pp.1699-707, 2015.
DOI : 10.1016/j.archoralbio.2015.09.001

S. S. Huja, Effects of Short-Term Zoledronic Acid Treatment on Bone Remodeling and Healing at Surgical Sites in the Maxilla and Mandible of Aged Dogs, Journal of Oral and Maxillofacial Surgery, vol.69, issue.2, pp.418-445, 2011.
DOI : 10.1016/j.joms.2010.05.062

S. Ishtiaq, The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells, Cytokine, vol.71, issue.2, pp.154-60, 2015.
DOI : 10.1016/j.cyto.2014.10.025

T. Jakobsen, Local bisphosphonate treatment increases fixation of hydroxyapatite-coated implants inserted with bone compaction Journal of orthopaedic research : official publication of the Orthopaedic Research Society, pp.189-94, 2009.

S. Javed and K. Kohli, Local Delivery of Minocycline Hydrochloride: A Therapeutic Paradigm in Periodontal Diseases, Current Drug Delivery, vol.7, issue.5, pp.398-406, 2010.
DOI : 10.2174/156720110793566290

S. Kalyan, T cells predict osteonecrosis of the jaw? An immunological perspective on the adverse drug effects of aminobisphosphonate therapy, Journal of Bone and Mineral Research, vol.20, issue.4, pp.728-763, 2013.
DOI : 10.1097/01.aids.0000238409.90571.02

A. Kamoun-goldrat, D. Ginisty, and M. Le-merrer, Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta, European Journal of Oral Sciences, vol.14, issue.2, pp.195-198, 2008.
DOI : 10.1007/s002230010047

J. A. Karasneh, Modified protocol including topical minocycline in orabase to manage medication-related osteonecrosis of the jaw cases, Journal of Oral Pathology & Medicine, vol.52, issue.9, pp.718-720, 2016.
DOI : 10.1016/j.archoralbio.2006.10.005

A. A. Khan, Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus, Journal of Bone and Mineral Research, vol.37, issue.9, pp.3-23, 2015.
DOI : 10.1016/j.bjoms.2005.05.012

J. W. Kim, Biomarkers for Bisphosphonate-Related Osteonecrosis of the Jaw, Clinical Implant Dentistry and Related Research, vol.17, issue.2, pp.281-291, 2015.
DOI : 10.1634/theoncologist.2011-0202

K. M. Kim, Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw, Osteoporosis International, vol.71, issue.Suppl 4, pp.1625-1632, 2014.
DOI : 10.1016/j.joms.2013.02.016

F. P. Koch, The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro, Head & Face Medicine, vol.100, issue.1, p.12, 2010.
DOI : 10.1172/JCI119668

F. P. Koch, The influence of bisphosphonates on human osteoblast migration and integrin aVb3/tenascin C gene expression in vitro, Head & Face Medicine, vol.10, issue.Pt 13, p.4, 2011.
DOI : 10.1006/mcne.1997.0643

A. Kolokythas, Salivary Biomarkers Associated With Bone Deterioration in Patients With Medication-Related Osteonecrosis of the Jaws, Journal of Oral and Maxillofacial Surgery, vol.73, issue.9, pp.1741-1747, 2015.
DOI : 10.1016/j.joms.2015.03.034

H. R. Kourie, Osteonecrosis of the jaw during biyearly treatment with zoledronic acid for aromatase inhibitor associated bone loss in early breast cancer: A literature review, Journal of Bone Oncology, vol.4, issue.3, pp.77-86, 2015.
DOI : 10.1016/j.jbo.2015.09.001

C. Kumar, Zoledronate for Osteogenesis imperfecta: evaluation of safety profile in children, Journal of Pediatric Endocrinology and Metabolism, vol.90, issue.8, pp.1-6, 2016.
DOI : 20149053641

M. A. Lawson, The Pharmacological Profile of a Novel Highly Potent Bisphosphonate, 2017.

J. Lee, Adult height and head and neck cancer: A pooled analysis within the INHANCE Consortium. Head and Neck, pp.1366-1371, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01261722

F. Lézot, Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies, Bone, vol.68, pp.146-152, 2014.
DOI : 10.1016/j.bone.2014.08.018

F. Lézot, Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: Mouse strain disparities and synergic effect with zoledronic acid, Bone, vol.73, pp.7351-7360, 2015.
DOI : 10.1016/j.bone.2014.12.011

Y. Li, Allogeneic Mesenchymal Stem Cell Therapy for Bisphosphonate-Related Jaw Osteonecrosis in Swine, Stem Cells and Development, vol.22, issue.14, pp.2047-2056, 2013.
DOI : 10.1089/scd.2012.0615

A. A. Lloyd, Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance, Proceedings of the National Academy of Sciences, vol.31, issue.33, pp.8722-8727, 2017.
DOI : 10.1002/jbmr.2759

T. Lombard, Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches, Stem Cells International, vol.76, issue.12, pp.1-16, 2016.
DOI : 10.1016/j.bone.2015.01.011

A. Marcano, Are Race and Sex Associated With the Occurrence of Atypical Femoral Fractures?, Clinical Orthopaedics and Related Research??, vol.93, issue.3, pp.1020-1027, 2014.
DOI : 10.1302/0301-620X.93B10.26924

R. E. Marx, J. E. Cillo, and J. J. Ulloa, Oral Bisphosphonate-Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and Treatment, Journal of Oral and Maxillofacial Surgery, vol.65, issue.12, pp.652397-2410, 2007.
DOI : 10.1016/j.joms.2007.08.003

Z. Mihaylova, Use of platelet concentrates in oral and maxillofacial surgery: an overview, Acta Odontologica Scandinavica, vol.14, issue.1, pp.1-11, 2016.
DOI : 10.4103/2231-0746.83158

P. C. Mohan, Radiographic features of multifocal endosteal thickening of the femur in patients on long-term bisphosphonate therapy, European Radiology, vol.278, issue.1, pp.222-227, 2013.
DOI : 10.1590/S0100-879X2009000400004

M. Moon, Sphingosine-1-phosphate inhibits the adipogenic differentiation of 3T3-L1 preadipocytes, International Journal of Molecular Medicine, vol.34, issue.4, pp.1153-1161, 2014.
DOI : 10.3892/ijmm.2014.1856

G. Moriceau, Therapeutic Approach of Primary Bone Tumours by Bisphosphonates, Current Pharmaceutical Design, vol.16, issue.27, pp.2981-2988, 2010.
DOI : 10.2174/138161210793563554
URL : https://hal.archives-ouvertes.fr/inserm-00511241

M. Muderis and A. T. , Zebra Lines of Pamidronate Therapy in Children, The Journal of Bone and Joint Surgery-American Volume, vol.89, issue.7, pp.1511-1516, 2007.
DOI : 10.2106/00004623-200707000-00015

T. Oizumi, Inhibition of Necrotic Actions of Nitrogen-Containing Bisphosphonates (NBPs) and Their Elimination From Bone by Etidronate (a Non-NBP): A Proposal for Possible Utilization of Etidronate as a Substitution Drug for NBPs, Journal of Oral and Maxillofacial Surgery, vol.68, issue.5, pp.681043-54, 2010.
DOI : 10.1016/j.joms.2009.08.027

S. Okada, Inhibition of Phosphate Transporters Ameliorates the Inflammatory and Necrotic Side Effects of the Nitrogen-Containing Bisphosphonate Zoledronate in Mice, The Tohoku Journal of Experimental Medicine, vol.231, issue.2, pp.145-58, 2013.
DOI : 10.1620/tjem.231.145

S. Osasan, Osteogenic Sarcoma: A 21st Century Review, Anticancer Research, vol.36, issue.9, pp.4391-4398, 2016.
DOI : 10.21873/anticanres.10982

B. Pan, The Nitrogen-Containing Bisphosphonate, Zoledronic Acid, Influences RANKL Expression in Human Osteoblast-Like Cells by Activating TNF-?? Converting Enzyme (TACE), Journal of Bone and Mineral Research, vol.347, issue.1, pp.147-154, 2004.
DOI : 10.1359/jbmr.2004.19.1.147

C. Pautke, Bisphosphonate related osteonecrosis of the jaw: A minipig large animal model, Bone, vol.51, issue.3, pp.592-599, 2012.
DOI : 10.1016/j.bone.2012.04.020

R. H. Preidl, Osteonecrosis of the jaw in a Crohn???s disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report, BMC Gastroenterology, vol.271, issue.1, p.6, 2014.
DOI : 10.1111/j.1365-2796.2012.02515.x

F. Rauch, Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta, Bone, vol.40, issue.4, pp.821-827, 2007.
DOI : 10.1016/j.bone.2006.11.020

F. Rauch, Risedronate in the Treatment of Mild Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study, Journal of Bone and Mineral Research, vol.24, issue.7, pp.1282-1289, 2009.
DOI : 10.1359/jbmr.090213

F. Rauch, R. Travers, and F. H. Glorieux, Pamidronate in Children with Osteogenesis Imperfecta: Histomorphometric Effects of Long-Term Therapy, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.2, pp.511-516, 2006.
DOI : 10.1210/jc.2005-2036

M. J. Rogers, Biochemical and molecular mechanisms of action of bisphosphonates, Bone, vol.49, issue.1, pp.34-41, 2011.
DOI : 10.1016/j.bone.2010.11.008

V. Rollason, Interventions for treating bisphosphonate-related osteonecrosis of the jaw ( BRONJ ) ( Review ) Cochrane Library, pp.1-35, 2016.

S. L. Ruggiero and T. B. Dodson, American Association of Oral and Maxillofacial Surgeons position Paper on Medication-Related Osteonecrosis of the, 2014.

R. G. Russell, Bisphosphonates, Bone, vol.49, issue.1, pp.2-19, 2011.
DOI : 10.1016/B978-0-407-02273-7.50010-5

S. Rydziel, S. Shaikh, and E. Canalis, Platelet-derived growth factor-AA and -BB (PDGF-AA and -BB) enhance the synthesis of PDGF-AA in bone cell cultures., Endocrinology, vol.134, issue.6, pp.1342541-2546, 1994.
DOI : 10.1210/endo.134.6.8194480

A. Sandstrom, The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human V??9V??2??T Cells, Immunity, vol.40, issue.4, pp.490-500, 2014.
DOI : 10.1016/j.immuni.2014.03.003

K. Santhosh, Pentofixylline and tocopherol in the treatment of osteoradionecrosis of the jaw -An update, International Journal of pharma and Bio Sciences, vol.6, issue.2, pp.551-556, 2015.

E. L. Scheller, Bisphosphonates Inhibit Expression of p63 by Oral Keratinocytes, Journal of Dental Research, vol.189, issue.7, pp.894-903, 2011.
DOI : 10.1038/19539

D. Sharma, Animal models for bisphosphonate-related osteonecrosis of the jaws - an appraisal, Oral Diseases, vol.45, issue.8, pp.747-754, 2013.
DOI : 10.1016/j.oraloncology.2008.04.013

A. Skene, Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur, N Engl J Med, vol.362, issue.19, pp.1761-71, 2010.

E. J. Smith, Transient Disturbance in Physeal Morphology Is Associated With Long-Term Effects of Nitrogen-Containing Bisphosphonates in Growing Rabbits, Journal of Bone and Mineral Research, vol.114, issue.10, pp.1731-1772, 2005.
DOI : 10.1172/JCI200422087

A. P. Soares, Bisphosphonates: Pharmacokinetics, bioavailability, mechanisms of action, clinical applications in children, and effects on tooth development, Environmental Toxicology and Pharmacology, vol.42, pp.212-217, 2016.
DOI : 10.1016/j.etap.2016.01.015

V. Thumbigere-math, Salivary proteomics in bisphosphonate-related osteonecrosis of the jaw, Oral Diseases, vol.5, issue.Suppl 3, pp.46-56, 2015.
DOI : 10.1371/journal.pone.0015573

V. Thumbigere-math, Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy, Journal of Oral and Maxillofacial Surgery, vol.74, issue.4, pp.738-746, 2016.
DOI : 10.1016/j.joms.2015.09.028

P. Vescovi, Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT), Lasers in Medical Science, vol.57, issue.1, pp.101-113, 2010.
DOI : 10.1089/104454704774076172

M. C. Walsh and Y. Choi, Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond. Frontiers in immunology, vol.5, pp.1-11, 2014.

C. Walter, Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells, Clinical Oral Investigations, vol.79, issue.1, pp.35-41, 2010.
DOI : 10.1002/ar.a.20396

J. B. Weber, R. S. Camilotti, and M. E. Ponte, Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review, Lasers in Medical Science, vol.29, issue.7, pp.311261-1272, 2016.
DOI : 10.1089/pho.2010.2835

F. Wehrhan, Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment, Oral Diseases, vol.23, issue.90, pp.433-475, 2011.
DOI : 10.1359/jbmr.080511

S. Weinerman and G. L. Usera, Antiresorptive Therapies for Osteoporosis, Oral and Maxillofacial Surgery Clinics of North America, vol.27, issue.4, pp.555-560, 2015.
DOI : 10.1016/j.coms.2015.07.001

W. B. Williams and F. O-'ryan, Management of Medication-Related Osteonecrosis of the Jaw, Oral and Maxillofacial Surgery Clinics of North America, vol.27, issue.4, pp.517-525, 2015.
DOI : 10.1016/j.coms.2015.06.007

Z. Yang, Local Application of Ibandronate/Gelatin Sponge Improves Osteotomy Healing in Rabbits, PLOS ONE, vol.34, issue.Suppl 2, 2015.
DOI : 10.1371/journal.pone.0125807.s001

E. D. Zhu, Effect of Bisphosphonates on the Rapidly Growing Male Murine Skeleton, Endocrinology, vol.155, issue.4, pp.1188-96, 2014.
DOI : 10.1210/en.2013-1993